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PreviewsSchwitalla et al., 2013). To address this
Zhou and colleagues administered a
3 day pulse of rSpon1 and rSlit2 to
ApcMin/+ mice treated with DSS to accel-
erate intestinal tumor formation and
exposed to the chemotherapy agent 5-
FU. Remarkably, not only was life span
significantly increased, but this treatment
was associated with a marked decrease
in the number of intestinal tumors. In this
experiment, the 5-FU only group died
before the end of therapy, and thus it’s
hard to know whether the reduction of
tumorigenesis in the rSpon1 and rSlit2
mice was comparable with what would
have been observed with 5-FU alone.
However, it is tempting to speculate that
these results might support the ‘‘just
right’’ model for Wnt signaling during tu-
mor formation. This model suggests that
there is an optimal window of Wnt
signaling required for tumorigenesis and
that very high Wnt signaling, as induced
here by rSpon1 and rSlit2, is actually
cytotoxic and kills transformed cells (Al-
buquerque et al., 2002; Me´niel et al.,
2013). Further work is required to deter-
mine the effect of this combination on
cancer cells and normal cells; many other
epithelial cells, e.g., skin, express both
Lgr4–6 receptors and thus could be acti-
vated if they also express the ROBO re-514 Cell Stem Cell 13, November 7, 2013 ª2ceptor. Moreover, recent studies have
shown the SLIT/ROBO pathway as a
key new axis identified by the TGCA
sequencing consortia (Biankin et al.,
2012); thus, the impact of thesemutations
would be important to ascertain if pa-
tients undergoing chemoradiotherapy
were to be cotreated with rSpon1 and
rSlit2.
In summary, this work holds exciting
translational promise to alleviate the
severe side effects of chemoradiother-
apy. Moreover, the key concern of a
promotion of tumorigenesis was not
found in this preliminary study, and
there is even a possibility that there
might be a beneficial effect by over-
activating the Wnt signaling pathway
in tumor cells during chemotherapy.
Finally, given the fact that Lgr5 has
recently been found to be expressed on
many regenerating epithelial cells, e.g.,
liver, it is possible that if the Slit/Robo
pathway is also active in these cells,
there could be broad implications for
the use of rSpon1/rSlit2 treatment for
regenerative medicine.REFERENCES
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The microenvironment within the bone marrow that maintains hematopoietic stem cell (HSC) quiescence
is the subject of intense study. In a recent Nature paper, Kunisaki et al. combine imaging techniques and
computational modeling to define a novel arteriolar niche for quiescent HSCs within the bone marrow.The hematopoietic stem cell (HSC) niche
is a spatially confined unit within the
bone marrow cavity that uniquely regu-
lates the choice between HSC quies-cence and proliferation (Schofield, 1978).
In suchmicroenvironments, HSCs receive
regulatory signals from neighboring or
adjacent cells, the extracellular matrix,and soluble factors. During the past
decade, the existence of at least two
subcompartments of the HSC niche has
been considered. The endosteal niche,
vascular
niche
endosteal niche endosteal niche
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Figure 1. Prevailing and New Views of the Hematopoietic Stem Cell Niche
The prevailing view of the hematopoietic stem cell niche in the bone marrow, with HSCs residing close to
either the vasculature or the endosteal surface (left). Kunisaki et al. demonstrate the coexistence of mul-
tiple vascular niches in the bone marrow, with the arteriolar niche maintaining quiescent HSCs while the
sinusoidal niche supports cycling HSCs (right).
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Previewshallmarked by osteoblasts lining the bone
marrow cavity, has been proposed as a
source of factors important for HSC
quiescence, while the vascular sinusoidal
niche has been implicated in HSC main-
tenance and regeneration (Adams and
Scadden, 2006; Kiel et al., 2005). Accu-
mulating evidence, however, argues that
considerable overlap exists between
HSC microenvironments. Recent studies
suggest that the HSC vascular niche
may not be limited to sinusoids, since
hematopoietic stem and progenitor cells
also lie adjacent to diverse nonsinusoidal
vascular structures including arteries
and arterioles (Nombela-Arrieta et al.,
2013). Direct visualization of the HSC
niche has proven challenging due to tech-
nical limitations in the imaging of skeletal
bones, the need for multiparameter
marker combinations to detect rare HSC
populations, and the ability to analyze
large cell populations at the single-cell
level in situ.
In a recent article in Nature, Kunisaki
et al. (2013) describe a novel, sophisti-
cated 3D imaging approach to analyze
the spatial relationship between endoge-
nous HSCs and vascular structures. The
studies were carried out in long bones
and also in the sternum. The latter offers
the advantage that all HSCs can be
enumerated, allowing for accurate quanti-
tation in 3D reconstructions. The authors
find that the phenotypically rare CD150+,
CD48, CD41, LineageHSCs preferen-
tially localize in the periphery of the bonemarrow, in close proximity to the endos-
teum. This region, referred to as the
endosteal zone, contains both sinusoids
and thin-walled arterioles. The majority
of HSC were associated with sinusoids
(67%werewithin 20 mm from sinusoids),
while a smaller fraction (37%) resided
close or adjacent to Sca-1hi, VEGFR2+,
VEGFR3 arterioles. The association
with sinusoids, however, is statistically
indistinguishable from a random distribu-
tion, since the bone marrow contains
a very dense sinusoidal network with a
regular spacing of 46 mm. Thus, any
randomly placed cell in the bone marrow
will be <23 mm (half the intervessel
spacing) away from the nearest sinusoidal
vessel. Using computational simulations,
Kunisaki et al. showed that, in contrast
to the random association of HSCs with
sinusoids, the association of HSCs with
arterioles is specific and statistically
nonrandom since these endosteal arteri-
oles comprise a much smaller volumetric
fraction of the bone marrow.
The authors then utilized a combination
of novel in situ imaging techniques and
a series of transgenic mouse models
to define the distinctive features of the
arteriolar and sinusoidal vascular niches.
First, the two vascular niches contain
phenotypically and molecularly unique
mesenchymal stromal cells. The arteriolar
stromal niche cells are defined as
Nestin-GFPbright, NG2+, LepR pericytes,
whereas the sinusoidal stromal niche cells
are described as Nestin-GFPdim, NG2,Cell Stem Cell 13,LepR+ cells with reticular morphology.
Second, the arteriolar niche cells are
quiescent while their counterparts in the
sinusoidal niche are actively cycling cells.
Remarkably, quiescent HSCs are also
distributed near the quiescent arteriolar
niche cells, and mobilization of HSCs
following treatment with G-CSF or alter-
ation of their cycling patterns via pharma-
cologic or genetic manipulations led to
a redistribution of HSCs away from the
arteriolar niche. Depletion of NG2+ peri-
cytes similarly results in the loss of HSC
quiescence, changes in HSC localization,
and overall reduction in HSC pool size. It
is unclear, however, how the quiescent
state is regulated.
One prevailing model involving stem
cells in general, i.e., pluripotent cells and
tumor stem cells, as well as adult stem
cells, is the influence of a hypoxic environ-
ment on cell quiescence and metabolism
(Suda et al., 2011). The bone marrow
cavity is regarded to be a physiologically
hypoxic tissue (estimated range between
1% and 6%O2) and it has been proposed
that quiescent HSCs reside in zones with
the deepest hypoxia (Parmar et al.,
2007), which are commonly thought to
be in the endosteal region away from
vascular structures. The findings of Kuna-
saki et al. differ from this existing view in
significant ways (Figure 1). The authors
show that the endosteal region is not
only endowed with sinusoidal blood
vessels (Kiel et al., 2005), but also with
arteriolar vessels that carry oxygenated
blood to the bone marrow. Several inde-
pendent lines of evidence are consistent
with this data. In vivo 3D imaging of
mouse calvaria has shown the endosteal
zone to be perivascular (Lo Celso et al.,
2009). Studies in long bones (Nombela-
Arrieta et al., 2013) have clearly demon-
strated the close association between
hematopoietic stem and progenitor cells
with small arterioles, which transition
into the venous system and likely repre-
sent the major site of oxygen exchange,
as occurs in other tissues. Moreover, he-
matopoietic stem and progenitor cells
display a characteristic hypoxic profile
independent of their localization in bone
marrow, adjacency to vascular structures,
or cell cycle status (Nombela-Arrieta
et al., 2013).
The quiescent state and self renewal
potential of HSCs have also been tightly
linked to their metabolic state. It isNovember 7, 2013 ª2013 Elsevier Inc. 515
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Previewsconceivable that extrinsic factors, both
cellular and soluble, in the HSC niche
could influence the balance between
glycolysis and oxidative metabolism
(Suda et al., 2011), and hence HSC acti-
vation. Gaining deeper insight into the
metabolic profile of HSCs, ideally in
the context of the oxygen availability in
the bone marrow microenvironment, will
be fundamental to understanding HSC
fate decisions in vivo. Recently, the role
of the sympathetic nervous system has
also received considerable attention
(Katayama et al., 2006). Interestingly,
the periarteriolar mesenchymal stromal
niche cells are highly innervated with
sympathetic nerves and Schwann cells,
which play a crucial role in steady state
HSC homeostasis as well as G-CSF
induced mobilization (Kunisaki et al.,
2013).
These data highlight increasing appre-
ciation of the importance of the HSC516 Cell Stem Cell 13, November 7, 2013 ª2niche. Future development of imaging
approaches complemented by computa-
tional methods for automated, objective
data acquisition will certainly advance
the field. Moreover, transgenic mouse
models will continue to provide excellent
tools to manipulate the niche and
assess the in vivo function of individual
niche components. Combining these
approaches, as highlighted by Kunisaki
et al., will yield further insights, and our
knowledge of the HSC niche under phys-
iologic conditions is rapidly evolving.
Future studies will undoubtedly build on
this work, providing valuable insights
into questions such as how the niche is
affected by aging and by inflammatory
and/or malignant conditions.REFERENCES
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